Werewolf Therapeutics (HOWL) Leases (2021 - 2025)
Werewolf Therapeutics (HOWL) has disclosed Leases for 5 consecutive years, with $5.2 million as the latest value for Q4 2025.
- Quarterly Leases fell 13.08% to $5.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.2 million through Dec 2025, down 13.08% year-over-year, with the annual reading at $5.2 million for FY2025, 13.08% down from the prior year.
- Leases for Q4 2025 was $5.2 million at Werewolf Therapeutics, down from $5.4 million in the prior quarter.
- The five-year high for Leases was $13.4 million in Q4 2021, with the low at $2.0 million in Q3 2021.
- Average Leases over 5 years is $6.7 million, with a median of $6.4 million recorded in 2024.
- Peak annual rise in Leases hit 386.07% in 2022, while the deepest fall reached 36.9% in 2022.
- Over 5 years, Leases stood at $13.4 million in 2021, then tumbled by 36.9% to $8.5 million in 2022, then decreased by 18.61% to $6.9 million in 2023, then dropped by 12.88% to $6.0 million in 2024, then decreased by 13.08% to $5.2 million in 2025.
- According to Business Quant data, Leases over the past three periods came in at $5.2 million, $5.4 million, and $5.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.